Skip to main content
. 2022 May 18;14:869507. doi: 10.3389/fnagi.2022.869507

FIGURE 2.

FIGURE 2

Cholinergic and monoaminergic systems mediate potential pathways for exercise amelioration in Alzheimer’s disease. 5-HT, 5-hydroxytryptamine; 5-HTR, 5-hydroxytryptamine receptor; ACh, acetylcholine; AChE, acetylcholinesterase; AR, adrenergic receptor; ChAT, choline acetyltransferase; DA, dopamine; mAChR, muscarinic acetylcholine receptor; MAOA, monoamine oxidase A; NE, norepinephrine.